Some NHS patients could be prescribed the Wegovy weight-loss drug after limited stock arrived in the UK.
The injection will be offered by some specialist NHS weight-loss management services, as well as some private clinics.
As doses become available, it could help tens of thousands of patients in England, the NHS said.
There has been a global shortage of the jabs, which blunt appetite. The cost to the health service is unclear.
www.bbc.co.uk/news/health-66681892
What is Wegovy®?
WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine that may help adults and children aged ≥12 years with obesity (BMI ≥30 for adults, BMI ≥ 95th percentile for age and sex for children), or some adults with excess weight (BMI ≥27) (overweight) who also have weight-related medical problems to help them lose weight and keep it off. Wegovy® should be used with a reduced calorie meal plan and increased physical activity
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines
It is not known if Wegovy® is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products
It is not known if Wegovy® can be used safely in people with a history of pancreatitis
It is not known if Wegovy® is safe and effective for use in children under 12 years of age
h/t A Deplorable Neanderthal